The ovaries are the primary female reproductive organs.
卵巢是女性的主要生殖器官。
Ovarian cancer is a type of cancer that begins in the ovaries.
卵巢癌是一种始于卵巢的癌症。
Menopause occurs when the ovaries stop producing eggs.
更年期发生在卵巢停止排卵时。
Regular exercise can help reduce the risk of
ovarian cysts.
有规律的锻炼有助于降低卵巢囊肿的风险。
Hormones produced by the ovaries regulate the menstrual cycle.
卵巢分泌的激素调节月经周期。
Ovarian torsion is a medical emergency where the ovary twists on itself.
卵巢扭转是一个医学紧急情况，卵巢在其自身上扭转。
Some women opt for
ovarian preservation during chemotherapy to preserve fertility.
一些女性在化疗期间选择保留卵巢以保护生育能力。
Ovarian hyperstimulation syndrome can occur with fertility treatments.
在生育治疗中可能会发生卵巢过度刺激综合症。
Early detection of
ovarian cancer significantly improves survival rates.
卵巢癌的早期发现显著提高存活率。
The function of the ovaries declines with age, leading to menopause.
随着年龄的增长，卵巢的功能会下降，导致更年期。
At CIIE 2019, AstraZeneca's cardiovascular and oncology departments also signed partnership agreements with enterprises from India and the United Kingdom, among the first batch of resident companies to develop comprehensive concrete collaborations regarding electrocardiogram diagnosis and ovarian cancer screening.
在2019年进博会期间，阿斯利康的心血管和肿瘤部门也与来自印度和英国的企业签署了合作协议，成为首批入驻并开展全面具体合作的企业之一，合作内容涉及心电图诊断和卵巢癌筛查。
Zejula (Niraparib), a cancer drug Zai Lab developed in partnership with Tesaro Inc, was recently acquired by British pharmaceutical giant GlaxoSmithKline Plc, and gained the approval in Hong Kong for the second line maintenance treatment of ovarian cancer last year.
Upon filing a new drug application, the drug was granted priority review status by the Center for Drug Evaluation, which is part of China's National Medical Products Administration, for the second line maintenance treatment of adult patients with recurrent epithelial, ovarian, fallopian tube or primary peritoneal ovarian cancer who are in a complete or partial response to platinum-based chemotherapy.
With the seventh World Ovarian Cancer Day falling May 8, a forum on ovarian cancer prevention and treatment was held Tuesday in Beijing by Health Times, a health publication affiliated with People's Daily.
Industry figures attending called for increased efforts to develop domestically produced drugs, as well as the promotion of standardized treatment procedures, both of which are needed to provide better disease care to ovarian cancer patients in China.
Wu Lingying, director of the gynecological oncology department of Cancer Hospital, Chinese Academy of Medical Sciences, said because ovarian cancer is relatively difficult to detect, about 70 percent of ovarian cancer patients are diagnosed in relatively late stages, and the majority of patients will have cancer relapses.
Liu Wengui, founder of Mijian 360. com, an online community for cancer patients and their families, said that a lot of new drugs and treatments have emerged for many other cancers in recent years, but not for ovarian cancer.
Liang Yi, chief commercial officer and China president at Zai Lab, a biopharmaceutical company based in Shanghai, said compared to other cancers that affect large populations, ovarian cancer does not receive enough attention from both the pharmaceutical industry and the public in China.
The drug is for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal ovarian cancer who are in a complete or partial response to platinum-based chemotherapy.
未经许可，严禁转发。QQ交流群：688169419